R. Lotti

Assessment of functional capacity with cardiopulmonary exercise testing in non-severe COVID-19 patients at three months follow-up

L. C. Bottaro, I. Porto, A. Hautala, 2020, medRxiv.

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jan van den Berg, Louis B. Bartels, H. Heidbuchel, 2022, The Lancet.

Cardiopulmonary exercise testing in COVID-19 patients at 3 months follow-up

L. C. Bottaro, G. Parati, I. Porto, 2021, International Journal of Cardiology.

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study.

Jan van den Berg, H. Heidbuchel, S. Connolly, 2022, Lancet.

Speckle-tracking echocardiography: state of art and its applications.

I. Porto, G. M. Rosa, R. Della Bona, 2021, Minerva medica.